Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year follow-up of more than 13,000 patients from the ETNA-AF-Europe study

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation stroke prevention with oral anticoagulants in difficult cases Oral Anticoagulation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by